SCYX
SCYNEXIS Inc.
Company Overview
| Mkt Cap | $29.98M | Price | $0.66 |
| Volume | 434.48K | Change | -3.93% |
| P/E Ratio | -1.4 | Open | $0.69 |
| Revenue | $3.7M | Prev Close | $0.69 |
| Net Income | $-21.3M | 52W Range | $0.65 - $1.49 |
| Div Yield | N/A | Target | $4.67 |
| Overall | 37 | Value | 60 |
| Quality | 34 | Technical | 18 |
No chart data available
Stock Overview
Updated DailySCYNEXIS Inc. (SCYX) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $0.66 with a market capitalization of $29.98 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 34.
Today's trading session shows SCYX with a volume of 434K shares. The stock opened up 0.39% from yesterday's close of $0.69. Current analyst estimates project earnings of $-0.73 per share for this year, with next year targeting $1.46.
SCYX demonstrates concerning technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including GLMD, KMPH, CTLT, CPRX.
Key investment considerations for SCYX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 607.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:02 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SCYX | $0.66 | -3.9% | 434.48K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |